ATH 33.3% 0.4¢ alterity therapeutics limited

potential blood test early alzheimers, page-4

  1. 1,300 Posts.
    lightbulb Created with Sketch. 6
    the earlier the detection the sooner people start PBT2 it may even stop full blown alzheimers developing our $10b market for PBT2 just doubled to $20b

    our market cap potentially quadzillioned

    can it also stop brain shrinkage in shorters?

    GLTAH
 
watchlist Created with Sketch. Add ATH (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.